Streetbeat News

Products Services

AAPL

HNHPF

NIO

TSLA

Sharp and Foxconn have unveiled an innovative electric vehicle prototype, the LDK+, at Sharp Tech-Day in Tokyo. This collaboration marks Foxconn's strategic entry into the EV market, diversifying from its role as a key Apple supplier. The LDK+ features a room-like interior and advanced AI technology, highlighting the growing importance of personal space in vehicles. Foxconn's investment in Vietnam for EV parts production further underscores its commitment to becoming a major player in the EV industry.

Portfolio Pulse from Benzinga Neuro

September 18, 2024 | 12:22 pm

CERT

Certara, Inc. (NASDAQ:CERT) collaborated with Ichnos Glenmark Innovation to optimize the dosing strategy for ISB 2001, a potential first-in-class cancer drug. The collaboration focused on first-in-human dose prediction using Certara's virtual clinical trial platform, enhancing patient safety and efficacy.

Portfolio Pulse from Benzinga Newsdesk

September 18, 2024 | 12:19 pm

PHGE

BiomX Inc. (NYSE:PHGE) will present data from its Phase 1b/2a clinical trial of BX004 for cystic fibrosis at the North American Cystic Fibrosis Conference. The study focuses on treating chronic Pseudomonas aeruginosa infections. Presentations will occur on September 27 and 28, 2024.

Portfolio Pulse from Benzinga Newsdesk

September 18, 2024 | 12:19 pm

LCTX

Lineage Cell Therapeutics presented preclinical data on its auditory neuronal cell transplant program, ReSonance, at the Inner Ear Biology Workshop. The program shows promise in treating hearing loss with a proprietary, scalable process.

Portfolio Pulse from Benzinga Newsdesk

September 18, 2024 | 12:15 pm

GH

Guardant Health announced that the journal 'Nature Medicine' has published results from the SCRUM-Japan GOZILA study. This publication could enhance the company's reputation in the medical research community.

Portfolio Pulse from Benzinga Newsdesk

September 18, 2024 | 12:12 pm

NVO

NanoVation Therapeutics has entered a multi-year partnership with Novo Nordisk to develop genetic medicines for cardiometabolic and rare diseases. The deal includes potential payments up to $600 million and tiered royalties.

Portfolio Pulse from Benzinga Newsdesk

September 18, 2024 | 12:11 pm

EVLV

Evolv Technology (NASDAQ:EVLV) is launching new security products, including the Evolv eXpedite™ bag scanner and Evolv Eva™ personal safety app, at the GSX conference. These innovations aim to enhance security by allowing seamless bag screening and personal safety integration.

Portfolio Pulse from Benzinga Newsdesk

September 18, 2024 | 12:11 pm

BIAF

bioAffinity Technologies' CyPath Lung test could save significant healthcare costs by reducing unnecessary follow-ups and complications in lung cancer detection, as per a peer-reviewed study. The test could have saved $379 million in 2022 for Medicare patients.

Portfolio Pulse from Benzinga Newsdesk

September 18, 2024 | 12:10 pm

COMM

CommScope has licensed AFL to manufacture its Prodigy fiber optic solution. This partnership aims to expand the reach and production capabilities of CommScope's Prodigy product line.

Portfolio Pulse from Benzinga Newsdesk

September 18, 2024 | 12:10 pm

ELUT

Elutia Inc. has published preclinical data showing that its product, EluPro, effectively eradicates bacteria associated with cardiac implant infections. This antibiotic-eluting bio-envelope, cleared by the FDA, reduces bacterial colonization with minimal systemic antibiotic exposure.

Portfolio Pulse from Benzinga Newsdesk

September 18, 2024 | 12:09 pm